14 Neurology And Neuroscience Therapeutics companies
Explore companies in Neurology And Neuroscience Therapeutics on Venture Capital Careers.
NFNoetic Fund
A venture fund investing in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies globally.
SVSCI Ventures
Invested in breaking through paralysis.
SLShannon Life Sciences
A venture capital firm uniquely dedicated to the frontier of neuroscience.
TVTakeda Ventures
Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.
TDThe Dementia Discovery Fund
A £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.
SISofinnova Investments
Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.
BVBioluminescence Ventures
We're biomedical researchers investing in a new generation of translational founders.
PSPalo Santo
Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solution…
ABAditum Bio
Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.
PVPsyMed Ventures
Investing in transformational technologies that elevate mental health and wellness.
8282VS
We are a venture studio leveraging Alloy’s pre-competitive drug discovery platforms. Established drug discovery, scientific, and lab resources allow entrepreneu…
TRTruVenturo
TruVenturo is one of Germany’s most successful internet company builders and independent investors. At TruVenturo, passionate entrepreneurs share the common vis…
AVAmgen Ventures
Since 2004, Amgen Ventures has invested in emerging companies to help discover promising medicines and technologies that will bring "Value Healthcare" to patien…
RVReeWire ventures
A CHF 50M venture capital fund aimed at supporting the development of neuroenhancement technologies.